Denmark-based Signia introduces Active Pro IX hearing aids with Prescription-Grade Sound

03rd September, 2024

Making innovative hearing technology more accessible

image credit- shutterstock

image credit- shutterstock

Denmark-based hearing aid innovator ‘Signia’ announced its new Signia Active Pro IX, a cutting-edge category of consumer earbuds that double as prescription-grade hearing aids and bring the power of conversation to even more people. Developed on Signia's Integrated Xperience (IX) technology, Signia Active Pro IX combines the capabilities of full prescription hearing aids with the modern design of consumer earbuds.

Integrated Xperience is the world's only hearing aid platform with a multi-stream architecture capable of pinpointing multiple moving conversation partners in real time. It can process up to four focus streams using Signia's RealTime Conversation Enhancement solution, which analyzes, augments, and adapts to the dynamic flow of multi-party conversation environments. This technology enables uninterrupted conversation engagement in noise, addressing a critical challenge many hearing aid wearers face.

In terms of user-friendly design and functioning, like consumer earbuds, they support Bluetooth connectivity for streaming audio and communicating via smartphone hands-free. With CallControl functionality, wearers can tap their Signia Active Pro IX earbuds to accept or decline calls.

In addition to Active Pro IX, Signia is also launching its Active IX earbuds, which feature the same modern earbud design at a different technology level. Active IX includes Signia's Augmented Focus technology, automatic directionality, and streaming audio connectivity, among other advanced features. The company is also announcing the launch of its Signia IX Essentials line of hearing aids in the US market. Signia IX Essentials expands the Integrated Xperience portfolio with extended performance levels 2IX and 1IX across select Signia Pure Charge&Go IX, Styletto IX, Silk Charge&Go IX, and Insio IX hearing aids.

 

 

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer